Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treating common mental disorder including psychotic experiences in the primary care improving access to psychological therapies programme (the TYPPEX study): protocol for a stepped wedge cluster randomised controlled trial with nested economic and process evaluation of a training package for therapists.
Ashford PA, Knight C, Heslin M, Clark AB, Kanaan M, Patel U, Stuart F, Kabir T, Grey N, Murray H, Hodgekins J, Reeve N, Marshall N, Painter M, Clarke J, Russo D, Stochl J, Leathersich M, Pond M, Fowler D, French P, Swart AM, Dixon-Woods M, Byford S, Jones PB, Perez J. Ashford PA, et al. Among authors: kabir t. BMJ Open. 2022 Jun 22;12(6):e056355. doi: 10.1136/bmjopen-2021-056355. BMJ Open. 2022. PMID: 35732378 Free PMC article.
Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
Buszewicz M, Cape J, Serfaty M, Shafran R, Kabir T, Tyrer P, Clarke CS, Nazareth I. Buszewicz M, et al. Among authors: kabir t. Health Technol Assess. 2017 Aug;21(45):1-138. doi: 10.3310/hta21450. Health Technol Assess. 2017. PMID: 28853392 Free PMC article. Clinical Trial.
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).
Lennox B, Yeeles K, Jones PB, Zandi M, Joyce E, Yu LM, Tomei G, Pollard R, Vincent SA, Shimazaki M, Cairns I, Dowling F, Kabir T, Barnes TRE, Lingford Hughes A, Hosseini AA, Harrower T, Buckley C, Coles A. Lennox B, et al. Among authors: kabir t. Trials. 2019 Jun 7;20(1):331. doi: 10.1186/s13063-019-3336-1. Trials. 2019. PMID: 31174586 Free PMC article.
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange).
Freeman D, Yu LM, Kabir T, Martin J, Craven M, Leal J, Lambe S, Brown S, Morrison A, Chapman K, Dudley R, O'Regan E, Rovira A, Goodsell A, Rosebrock L, Bergin A, Cryer TL, Robotham D, Andleeb H, Geddes JR, Hollis C, Clark DM, Waite F. Freeman D, et al. Among authors: kabir t. BMJ Open. 2019 Aug 27;9(8):e031606. doi: 10.1136/bmjopen-2019-031606. BMJ Open. 2019. PMID: 31462489 Free PMC article.
Shared goals for mental health research: what, why and when for the 2020s.
Wykes T, Bell A, Carr S, Coldham T, Gilbody S, Hotopf M, Johnson S, Kabir T, Pinfold V, Sweeney A, Jones PB, Creswell C. Wykes T, et al. Among authors: kabir t. J Ment Health. 2023 Dec;32(6):997-1005. doi: 10.1080/09638237.2021.1898552. Epub 2021 May 9. J Ment Health. 2023. PMID: 33966543
Comparison of a theoretically driven cognitive therapy (the Feeling Safe Programme) with befriending for the treatment of persistent persecutory delusions: a parallel, single-blind, randomised controlled trial.
Freeman D, Emsley R, Diamond R, Collett N, Bold E, Chadwick E, Isham L, Bird JC, Edwards D, Kingdon D, Fitzpatrick R, Kabir T, Waite F; Oxford Cognitive Approaches to Psychosis Trial Study Group. Freeman D, et al. Among authors: kabir t. Lancet Psychiatry. 2021 Aug;8(8):696-707. doi: 10.1016/S2215-0366(21)00158-9. Epub 2021 Jul 8. Lancet Psychiatry. 2021. PMID: 34246324 Free PMC article. Clinical Trial.
Cognitive bias modification for paranoia (CBM-pa): a randomised controlled feasibility study in patients with distressing paranoid beliefs.
Yiend J, Lam CLM, Schmidt N, Crane B, Heslin M, Kabir T, McGuire P, Meek C, Mouchlianitis E, Peters E, Stahl D, Trotta A, Shergill S. Yiend J, et al. Among authors: kabir t. Psychol Med. 2023 Jul;53(10):4614-4626. doi: 10.1017/S0033291722001520. Epub 2022 Jun 14. Psychol Med. 2023. PMID: 35699135 Free PMC article. Clinical Trial.
171 results